SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
🧫

Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in Parkinson's Disease

active
experiment Created: 2026-04-02T17:01:41 By: crosslink-v2 Quality: 67% ✓ SciDEX ID: experiment-exp-wiki-experiments-metal-io
🌍 Provenance Graph 10 nodes, 38 edges

derives from (16)

▸ Show 11 more

supports (5)

📊 Evidence Profile
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
708
Outgoing
656
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Linked Artifacts (1362)
mentions📖MCU100%
experiment_target📖FOXO3100%
mentions📖FOXO3100%
mentions📖GJA1100%
mentions📖parkinsons-disease97%
derives_from📖Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 95%
experiment_target🧪FOXO3-Longevity Pathway Epigenetic Reprogramming90%
experiment_target🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati90%
derives_from🧪CX43 hemichannel engineering enables size-selective mitochon90%
derives_from🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati90%
derives_from🧪TFAM overexpression creates mitochondrial donor-recipient gr90%
experiment_target🧪TFAM overexpression creates mitochondrial donor-recipient gr90%
experiment_target🧪CX43 hemichannel engineering enables size-selective mitochon90%
experiment_target🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m90%
derives_from🧪FOXO3-Longevity Pathway Epigenetic Reprogramming90%
derives_from🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m90%
related🧪CX43 hemichannel engineering enables size-selective mitochon85%
related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati85%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming85%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m85%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr85%
mentions📖FOXO3 Protein80%
supports🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati80%
supports🧪TFAM overexpression creates mitochondrial donor-recipient gr80%
mentions📖GJA1 Protein80%
supports🧪CX43 hemichannel engineering enables size-selective mitochon80%
supports🧪FOXO3-Longevity Pathway Epigenetic Reprogramming80%
mentions📖FOXO3 Protein (Forkhead Box O3)80%
supports🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m80%
mentions📖GJA170%
mentions📖dna-damage-repair70%
mentions📖DNA Methylation70%
mentions📖MCU Protein70%
mentions📖CSF Biomarkers for Corticobasal Syndrome and Progressive Sup70%
mentions📖PET Imaging for Neurodegenerative Diseases70%
mentions📖DNA Damage Repair Therapy - Biomarker Guided70%
mentions📖DNA Sensing Pathways in Neurodegeneration70%
related📖FOXO3 Protein (Forkhead Box O3)70%
mentions📖DNA Damage Repair Deficiency Hypothesis in Parkinson's 70%
mentions📖DNA Damage Response and Repair in Neurodegeneration70%
mentions📖DNA Damage Response in Neurodegeneration70%
mentions📖TFAM Protein70%
mentions📖DNA Damage Repair Therapy for Neurodegeneration70%
mentions📖DNA Damage Response in Corticobasal Syndrome70%
mentions📖CSF Dynamics and Glymphatic Therapy in CBS/PSP70%
mentions📖PET Imaging Combined with Fluid Biomarkers70%
related📖FOXO3 Gene70%
related📖FOXO3 Protein (Forkhead Box O3)70%
mentions📖DNA Ligase IV Protein70%
mentions📖DNA Damage Response in Parkinson's Disease70%
mentions📖DNA Methylation in Neurodegeneration70%
mentions📖DNA Repair Mechanisms in Neurodegeneration70%
mentions📖DNA Repair Therapy for Neurodegeneration70%
mentions📖DNA Damage Response Impairment Pathway70%
mentions📖DNA Damage Response in Neurons70%
mentions📖CSF Cytokine Profiles as Parkinson's Disease Biomarkers70%
mentions📖CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 70%
mentions📖DNA Damage-Accumulating Neurons in Neurodegeneration70%
mentions📖CSF Synaptic Biomarker Panel for Neurodegenerative Diseases70%
related📖GJA170%
mentions📖DNA Damage Repair Mechanisms Across Neurodegenerative Diseas70%
mentions📖CSF-1R Inhibitors70%
mentions📖CSF Biomarker Comparison Across Neurodegenerative Diseases70%
mentions📖DNA-PKcs (PRKDC) Protein70%
mentions📖DNA Methylation Biomarkers in Neurodegeneration70%
mentions📖ATP P2X3 Receptor Neurons70%
mentions📖MCU Gene70%
mentions📖DNA Ligase III Protein70%
mentions📖SAA and Imaging for Prodromal Parkinson's Disease Trial70%
mentions📖MRI Atrophy Patterns in CBS/PSP70%
mentions📖MRI and Imaging Findings in Corticobasal Syndrome70%
related📖FOXO3 Protein70%
mentions📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy70%
mentions📖CSF Neurofilament Light Chain (NfL) in Neurodegeneration70%
mentions📖FOXO3 Gene70%
mentions📖DNA Damage Response in Corticobasal Syndrome70%
mentions📖CSF O-GlcNAc — Target Engagement Biomarker for OGA Inhibitor70%
related📖MCU Protein70%
mentions📖MRI for Neurodegenerative Diseases70%
mentions📖DNA Damage Response in Alzheimer's Disease70%
related📖MCU Protein70%
related📖GJA1 Protein70%
related📖FOXO3 Protein70%
mentions📖saa-guided-alpha-synuclein-therapy70%
mentions📖DNA Damage and Repair in Neurons70%
related📖GJA1 Protein70%
related📖depression70%
mentions📖PET Imaging in Neurodegeneration70%
mentions📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy70%
mentions📖DNA Damage Response in Alzheimer's Disease70%
mentions📖DNA Damage Response in 4R-Tauopathies70%
mentions📖CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 70%
related📖Parkinson's Disease70%
related📖MCU Gene70%
mentions📖DNA Damage Repair Deficiency Validation Study in Parkinson&#70%
mentions📖DNA Damage and Repair Dysfunction in PSP70%
mentions📖TFAM Gene70%
mentions📖csf-pta18170%
mentions📖DNA Damage Repair Investment Landscape70%
related📖DNA Methylation63%
related📖DNA Damage and Repair Dysfunction in PSP63%
related📖DNA Damage Response in Alzheimer's Disease63%
related📖CSF O-GlcNAc — Target Engagement Biomarker for OGA Inhibitor63%
related📖DNA Damage-Accumulating Neurons in Neurodegeneration63%
related📖GJA163%
related📖MRI Atrophy Patterns in CBS/PSP63%
related📖saa-guided-alpha-synuclein-therapy63%
related📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy63%
related📖CSF-1R Inhibitors63%
related📖DNA Damage Repair Therapy for Neurodegeneration63%
related📖PET Imaging for Neurodegenerative Diseases63%
related📖DNA Repair Mechanisms in Neurodegeneration63%
related📖CSF Biomarkers for Corticobasal Syndrome and Progressive Sup63%
related📖CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 63%
related📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy63%
related📖PET Imaging in Neurodegeneration63%
related📖DNA Damage and Repair in Neurons63%
related📖DNA Methylation in Neurodegeneration63%
related📖DNA Sensing Pathways in Neurodegeneration63%
related📖MRI for Neurodegenerative Diseases63%
related📖DNA Damage Response in Neurodegeneration63%
related📖DNA Damage Repair Therapy - Biomarker Guided63%
related📖DNA Ligase IV Protein63%
related📖DNA Damage Response and Repair in Neurodegeneration63%
related📖DNA Repair Therapy for Neurodegeneration63%
related📖DNA Methylation Biomarkers in Neurodegeneration63%
related📖CSF Dynamics and Glymphatic Therapy in CBS/PSP63%
related📖DNA Damage Response in Alzheimer's Disease63%
related📖dna-damage-repair63%
related📖DNA Damage Response in Neurons63%
related📖DNA Damage Repair Mechanisms Across Neurodegenerative Diseas63%
related📖FOXO3 Gene63%
related📖CSF Synaptic Biomarker Panel for Neurodegenerative Diseases63%
related📖DNA Damage Response in 4R-Tauopathies63%
related📖ATP P2X3 Receptor Neurons63%
related📖MCU Gene63%
related📖DNA Damage Repair Investment Landscape63%
related📖PET Imaging Combined with Fluid Biomarkers63%
related📖DNA Damage Response in Corticobasal Syndrome63%
related📖CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 63%
related📖CSF Neurofilament Light Chain (NfL) in Neurodegeneration63%
related📖DNA-PKcs (PRKDC) Protein63%
related📖DNA Ligase III Protein63%
related📖MRI and Imaging Findings in Corticobasal Syndrome63%
related📖DNA Damage Response Impairment Pathway63%
related📖DNA Damage Response in Corticobasal Syndrome63%
related📖csf-pta18163%
related📖CSF Biomarker Comparison Across Neurodegenerative Diseases63%
related📖TFAM Gene63%
related📖TFAM Protein63%
related📖Enteric Nervous System Neurons in Parkinson's Disease60%
related📖Cav1.3 Calcium Channel Modulators for Parkinson's Disea60%
related📖Parkinson's Disease VEGF/Angiogenic Signaling Therapy C60%
related📖Multi-Ethnic Parkinson's Disease GWAS60%
related📖AMPK Activators for Parkinson's Disease60%
mentions📖Mitochondria60%
related📖Lateral Habenula in Parkinson's Disease60%
mentions📖Parkin60%
related📖LRRK2 Kinase Inhibition in Parkinson's Disease - Therap60%
related📖GLP-1 Receptor Agonists for Parkinson's Disease60%
related📖Sirtuin Signaling in Parkinson's Disease60%
related📖Stress Granule Dysfunction Validation in Parkinson's Di60%
related📖AADC Gene Therapy for Parkinson's Disease60%
related📖Ginsenosides Neuroprotection in Parkinson's Disease60%
related📖Exenatide for Parkinson's Disease60%
related📖TB006 for Parkinson's Disease60%
related📖Acupuncture Therapy for Parkinson's Disease60%
related📖Digital Therapeutics for Parkinson's Disease60%
related📖DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
related📖EMST with SpiroGym App for Parkinson's Disease (NCT069460%
related📖Alpha-Synuclein Prion-Like Spreading Mechanisms in Parkinson60%
related📖Ventral Tegmental Area Dopamine Neurons in Parkinson's 60%
related📖Apocynin for Parkinson's Disease60%
related📖Parkinson's Disease HIF/Hypoxia Signaling Therapy Compa60%
related📖Parkinson's Disease Subtypes60%
related📖Digital Diagnostic Devices for Parkinson's Disease (NCT60%
related📖VPS35 Pathway in Parkinson's Disease60%
mentions📖mitochondria60%
related📖Parkinson's Disease Treatment Overview60%
related📖iPSC Cell Therapy for Parkinson's Disease60%
related📖ER-Golgi Secretory Pathway Dysfunction Hypothesis in Parkins60%
related📖Insulin Signaling in Parkinson's Disease60%
related📖EGFR Signaling in Parkinson's Disease60%
related📖Coenzyme Q10 for Parkinson's Disease60%
related📖Peroxisomal Dysfunction Hypothesis in Parkinson's Disea60%
related📖Shared Proteinostasis Failure in Alzheimer's and Parkin60%
related📖Occupational Therapy for Parkinson's Disease60%
related📖PGC-1α and Mitochondrial Biogenesis Therapies for Parkinson&60%
related📖Dietary Interventions for Parkinson's Disease60%
related📖mRNA Therapy for Parkinson's Disease60%
related📖Efficacy of Acupuncture for Treatment of Parkinson's Di60%
related📖NLRP3 Inhibitors in Parkinson's Disease: Research and C60%
related📖Brain-Computer Interface for Parkinson's Disease60%
related📖GGC/Glutathione Antioxidant Enrichment for Parkinson's 60%
related📖JNK/p38 MAPK Inhibitor Companies for Parkinson's Diseas60%
related📖Senolytic Therapies for Parkinson's Disease60%
related📖JAK-STAT Signaling in Parkinson's Disease60%
related📖Purinergic Signaling Dysfunction Validation in Parkinson60%
related📖Portable Exoskeleton for Parkinson's Disease Mobility (60%
related📖Tocotrienols in Parkinson's Disease Trial (NCT04491383)60%
related📖Alpha-Synuclein Propagation in Parkinson's Disease60%
related📖Clostridium Butyricum for Motor and Non-motor Symptoms in Pa60%
related📖Macroautophagy Dysfunction Validation Framework in Parkinson60%
related📖Nigral Microglia in Parkinson's Disease60%
related📖Glial-Neuron Crosstalk in Parkinson's Disease60%
related📖Exercise-BDNF-Mitochondrial Resilience Hypothesis in Parkins60%
related📖Protein Phase Separation in Parkinson's Disease60%
related📖Anthony Lang — PSP and Parkinson's Disease Researcher60%
related📖NCT05881460: Vibrotactile Coordinated Reset for Parkinson&#x60%
related📖Icaritin GPER Mitophagy for Parkinson's Disease60%
related📖Parkinson's Disease Drug Repurposing Consortia60%
related📖Extracellular Vesicle-Mediated Synuclein Propagation Hypothe60%
related📖Sigma-2 Receptor Modulation for Parkinson's Disease60%
related📖Resilient Neurons in Parkinson's Disease60%
related📖TREM2 Agonist Therapy for Parkinson's Disease — Experim60%
related📖ACI-35 Alpha-Synuclein Vaccine for Parkinson's Disease60%
related📖Synaptic Dysfunction in Parkinson's Disease60%
related📖PI3K-Akt Signaling in Parkinson's Disease60%
related📖Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%
related📖MLCS Quantification in Parkinson's Disease60%
related📖Deep Brain Stimulation for Parkinson's Disease60%
mentions📖Neurodegeneration60%
related📖Ferroptosis Validation in Parkinson's Disease60%
related📖Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%
related📖Parkinson's Disease ER Stress/UPR Modulator Companies60%
related📖Sirtuin Modulators for Parkinson's Disease60%
mentions📖Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
related📖Dorsal Motor Nucleus of the Vagus in Parkinson's Diseas60%
related📖LRRK2-GBA Combination Therapy for Parkinson's Disease60%
related📖CVN424 Phase 3 Trial for Parkinson's Disease60%
related📖Autophagy-Lysosomal Pathway in Parkinson's Disease60%
related📖ATP13A9 and Parkinson's Disease60%
related📖Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%
related📖ABBV-951 (foslevodopa/foscarbidopa) for Parkinson's Dis60%
related📖Hippo Signaling Pathway in Parkinson's Disease60%
related📖Astrocyte-Targeted Parkinson's Disease Therapy Companie60%
related📖Lipid Raft Modulation for Parkinson's Disease (MLSM Hyp60%
related📖Zonisamide for Parkinson's Disease Motor Complications60%
related📖PARK16 - Parkinson's Disease Locus 1660%
related📖siRNA Therapy for Parkinson's Disease60%
related📖USP30 Inhibitors for Parkinson's Disease60%
related📖Mitochondria-Lysosome Contact Site Dysfunction in Parkinson&60%
related📖Pedunculopontine Nucleus in Parkinson's Disease60%
related📖cGAS-STING Pathway Dysregulation Hypothesis in Parkinson60%
related📖Fasudil for Parkinson's Disease (ROCK-PD)60%
related📖Wnt Signaling in Parkinson's Disease60%
related📖Pain and Autonomic Symptoms in Parkinson's Disease and 60%
related📖Partnered Dance Aerobic Exercise for Parkinson's Diseas60%
related📖Post-Acute Viral Reservoir Hypothesis in Parkinson's Di60%
related📖Korean Biotechnology Companies in Parkinson's Disease60%
related📖Symptomatic Treatments for Parkinson's Disease60%
related📖Laterodorsal Tegmental Nucleus Cholinergic Neurons in Parkin60%
related📖Synaptic Vesicle Trafficking Dysfunction Hypothesis in Parki60%
related📖Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%
related📖Notch Signaling in Parkinson's Disease60%
related📖P2X7 Receptor Antagonists for Parkinson's Disease60%
related📖Dorsal Raphe in Parkinson's Disease60%
related📖Dental Health and Oral Microbiome in Parkinson's Diseas60%
related📖BIA 28-6156 for GBA-Parkinson's Disease60%
related📖Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%
related📖Parkinson's Disease Subtype Classification — Precision 60%
related📖Vulnerable Neurons in Parkinson's Disease60%
related📖MDS 2026: Surgical Therapies for Parkinson's Disease60%
related📖Vagus Nerve Stimulation for Parkinson's Disease60%
related📖Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
related📖Exosome Therapy for Parkinson's Disease60%
related📖Laterodorsal Tegmental Nucleus Cholinergic Neurons in Parkin60%
related📖Parkinson's Disease Hypothesis Rankings60%
mentions📖biomarkers60%
related📖STING-CASM-GABARAP-LRRK2 Pathway in Parkinson's Disease60%
related📖Gut-First vs Brain-First Parkinson's Disease Trajectori60%
related📖European Academic Spin-out Companies in Parkinson's Dis60%
related📖Physical Exercise Therapy for Parkinson's Disease60%
related📖PARK7 (DJ-1) Targeted Therapy for Parkinson's Disease60%
related📖Neurotrophic Factor Signaling in Parkinson's Disease60%
related📖CT1-DAP001 iPS Cell-derived Dopaminergic Progenitors for Par60%
related📖Mitochondrial Dysfunction in Parkinson's Disease60%
related📖GPR37 Modulator Therapy for Parkinson's Disease60%
related📖Cellular Senescence Hypothesis in Parkinson's Disease60%
related📖Molecular Hydrogen Therapy for Parkinson's Disease60%
related📖Alzheimer's Disease vs Parkinson's Disease Compari60%
related📖Theta-Firing Dopamine Neurons in Parkinson's Disease60%
related📖Natural Killer Cells in Parkinson's Disease60%
related📖Regulated Necrosis Validation Study in Parkinson's Dise60%
related📖Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
related📖Nigrostriatal Dopamine Terminals in Parkinson's Disease60%
related📖Tai Chi for Parkinson's Disease60%
related📖Valacyclovir for HSV-1-Positive Parkinson's Disease60%
related📖Blood Flow Restriction for Optimizing Balance in Parkinson&#60%
related📖NUS1 CoQ10 Pathway Modulation for Parkinson's Disease60%
related📖DNA Damage Repair Deficiency Hypothesis in Parkinson's 60%
related📖Lichen-derived Neuroprotective Compounds for Parkinson'60%
related📖HIF/Hypoxia Signaling in Parkinson's Disease60%
related📖Paolo Barone — Parkinson's Disease and Movement Disorde60%
related📖Acupuncture Therapy for Parkinson's Disease60%
related📖GBA Therapy in Parkinson's Disease60%
related📖NCT05565443: MR-Guided Focused Ultrasound + GCase for Parkin60%
related📖Exercise-BDNF Signaling Axis Hypothesis in Parkinson's 60%
related📖Morris K. Udall Centers for Parkinson's Disease Researc60%
related📖Retromer-Endosomal Sorting Dysfunction Hypothesis in Parkins60%
related📖Coenzyme Q10 (CoQ10) for Parkinson's Disease60%
related📖CAR-T Cell Therapy for Parkinson's Disease60%
mentions📖Dopamine60%
related📖Continuous Dopaminergic Stimulation for Parkinson's Dis60%
related📖CR3-Dependent Microglial Synapse Elimination in Parkinson&#x60%
related📖NLRP3 Inflammasome Inhibitors for Parkinson's Disease60%
related📖Parkinson's Disease Mechanisms60%
related📖Peripheral Immune System in Parkinson's Disease60%
related📖GPR68 (OGR1) Modulator Therapy for Parkinson's Disease60%
related📖Thoracic Epidural SCS for Parkinson's Disease Freezing 60%
related📖Lipid Droplet-Lysosome Axis Dysfunction Hypothesis in Parkin60%
related📖Buntanetap Phase 3 Parkinson's Disease Trial (NCT07284760%
related📖AMPK Signaling in Parkinson's Disease60%
related📖PI3K/Akt Activator Clinical Trials for Parkinson's Dise60%
related📖Metformin for Parkinson's Disease - Phase 2/3 Trial (NC60%
related📖Optogenetics Therapy for Parkinson's Disease60%
related📖Vesicular Monoamine Transporter (VMAT) Modulators for Parkin60%
related📖AI-Powered Movement Analysis for Parkinson's Disease60%
related📖Olfactory Ensheathing Cells in Parkinson's Disease60%
related📖Exercise as Treatment of Fatigue in Parkinson's Disease60%
related📖SER-252 (PEOZ-Apomorphine) for Parkinson's Disease - NC60%
related📖Dopamine Transporter Modulators for Parkinson's Disease60%
related📖TGF-β Signaling in Parkinson's Disease60%
related📖Alpha-Synuclein Propagation Models in Parkinson's Disea60%
related📖Purinergic Signaling in Parkinson's Disease60%
mentions📖treatments60%
related📖Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
related📖Spinal Cord Stimulation for Freezing of Gait in Parkinson&#x60%
related📖UCHL1 Ubiquitin-Proteasome Parkinson's Disease Causal C60%
related📖Parkinson's Disease Mitochondrial Neuroprotection Compa60%
related📖Prasinezumab Phase 3 Parkinson's Disease Trial (NCT071760%
related📖MDS 2026: Neuroprotection and Neurorestorative Strategies fo60%
related📖ATP13A2 (PARK9) Targeting for Parkinson's Disease60%
related📖PINK1 Activators for Parkinson's Disease60%
related📖Mitochondrial Dynamics Modulators for Parkinson's Disea60%
related📖Epigenetic Therapies for Parkinson's Disease60%
related📖Neurturin (NRTN) Therapy for Parkinson's Disease60%
related📖AMP-PD: Accelerating Medicines Partnership: Parkinson's60%
mentions📖Parkin Protein60%
related📖Neural Oscillation Dysfunction Validation in Parkinson'60%
related📖Parkinson's Disease Biomarkers60%
related📖NRF2 Activators for Parkinson's Disease60%
related📖PARK2/Parkin Ubiquitin Ligase Pathway in Parkinson's Di60%
related📖Neurorestore Therapies for Parkinson's Disease60%
related📖NUS1 CoQ10 Pathway Modulation for Parkinson's Disease60%
related📖MDS 2026 — Precision Medicine in Parkinson's Disease60%
related📖Astrocyte-Neuron Metabolic Coupling Hypothesis in Parkinson&60%
related📖EC5026 (STEP Study) Phase 1 Parkinson's Disease Trial (60%
related📖Glymphatic System Clearance Dysfunction in Parkinson's 60%
related📖LRRK2 Kinase Activation and Endolysosomal Dysfunction in Par60%
related📖Parkinson's Disease DNA Damage Repair Therapeutic Compa60%
related📖LY4006896 Phase 1 Parkinson's Disease Trial60%
related📖Non-Motor Symptoms Treatment in Parkinson's Disease60%
related📖Mesenchymal Stem Cell Therapy for Parkinson's Disease60%
related📖DBS for Visuomotor Function in Parkinson's Disease (NCT60%
related📖MDS 2026 — Freezing of Gait and Postural Instability in Park60%
related📖Gut-Immune-Brain Axis Hypothesis in Parkinson's Disease60%
related📖Neurotensin Receptor Modulators for Parkinson's Disease60%
related📖Photobiomodulation Therapy for Parkinson's Disease60%
related📖Selegiline - MAO-B Inhibitor for Parkinson's Disease60%
related📖Ambroxol for Parkinson's Disease60%
related📖Antiviral Therapy Trial for Parkinson's Disease60%
related📖Parkinson's Disease Treatment60%
related📖Mediterranean Diet in Parkinson's Disease (NCT07187739)60%
related📖Vagal Nerve Stimulation for Parkinson's Disease (NCT07260%
related📖Mitochondrial Failure Nodes in Parkinson's Disease60%
related📖Vagal Nucleus Neurons in Parkinson's Disease60%
related📖Striatal Cholinergic Interneurons in Parkinson's Diseas60%
related📖Neuroinflammation in Parkinson's Disease60%
related📖GCase and Lysosomal Function in Parkinson's Disease60%
related📖JAK Inhibitors in Parkinson's Disease60%
related📖PINK1-Parkin Mitophagy Pathway in Parkinson's Disease60%
related📖Intranasal Therapy for Parkinson's Disease60%
related📖Biomarkers for Parkinson's Disease60%
related📖Parkinson's Disease NRF2-Keap1 Pathway Therapy Companie60%
related📖Hsp70/Hsp90 Chaperone Pathway in Parkinson's Disease60%
related📖Investment Landscape: Parkinson's Disease60%
related📖Sigma-1 Receptor Agonist Therapy for Parkinson's Diseas60%
related📖Mitochondria-Lysosome Contact Sites in Parkinson's Dise60%
related📖Enteric Neurons in Parkinson's Disease60%
related📖Autonomic Dysfunction in Parkinson's Disease60%
related📖SAA and Imaging for Prodromal Parkinson's Disease Trial60%
related📖Apoptosis Pathways in Parkinson's Disease60%
related📖Mixed Pathology Effects on Parkinson's Disease Progress60%
related📖Probiotic and Microbiome Therapy for Parkinson's Diseas60%
related📖Vesicular Monoamine Transporter 2 (VMAT2) Pathway in Parkins60%
related📖Alpha-Synuclein Propagation in Prodromal Parkinson's Di60%
related📖Wnt-Beta-Catenin Signaling Dysfunction Hypothesis in Parkins60%
related📖Nrf2 Signaling in Parkinson's Disease60%
related📖Notch Signaling in Parkinson's Disease60%
related📖RMF Therapy for Parkinson's Disease60%
related📖Parkinson's Disease Ferroptosis Companies60%
related📖mTOR Signaling in Parkinson's Disease60%
related📖GBA Glucocerebrosidase Pathway in Parkinson's Disease60%
related📖VPS35 Retromer Dysfunction Parkinson's Disease Causal C60%
related📖Tryptophan-Kynurenine Neurotoxicity Hypothesis in Parkinson&60%
related📖DANU Sports System for Gait/Balance Assessment in Parkinson&60%
related📖Wearable Sensors for Parkinson's Disease60%
related📖G-Protein Coupled Receptor Signaling in Parkinson's Dis60%
related📖Wearable Technologies for Parkinson's Disease60%
related📖GBA and Lysosomal Function in Parkinson's Disease60%
related📖GLP-1 Receptor Agonists for Parkinson's Disease60%
related📖Digital Biomarker Platforms for Parkinson's Disease60%
mentions📖Dopaminergic Neurons60%
related📖SNCA→Alpha-synuclein→Parkinson's Disease Causal Chain60%
related📖Oligodendrocyte-Myelin Dysfunction Hypothesis in Parkinson&#60%
related📖Astrocytes in Parkinson's Disease Neurodegeneration60%
related📖Axonal Transport Dysfunction Validation in Parkinson's 60%
related📖Enteric Neurons in Parkinson's Disease60%
related📖NouvNeu001 Cell Therapy for Parkinson's Disease60%
related📖Dopaminergic Neuron Vulnerability in Parkinson's Diseas60%
related📖Parkinson's Disease EGFR Signaling Therapy Companies60%
related📖Tributyrin for Parkinson's Disease60%
related📖Peroxisome Dysfunction Validation in Parkinson's Diseas60%
related📖ARC-IM Adaptive Neurostimulation for Parkinson's Diseas60%
related📖GDNF Therapy for Parkinson's Disease60%
related📖Parkinson's Disease Metabolism60%
related📖Amino Acid Supplementation in Parkinson's Disease60%
related📖VEGF Angiogenesis Therapy for Parkinson's Disease60%
related📖Glymphatic Waste Clearance Therapy for Parkinson's Dise60%
related📖LRRK2 Pathway in Parkinson's Disease60%
related📖Epigenetic Therapies for Parkinson's Disease60%
related📖Physical Therapy for Parkinson's Disease60%
related📖Olfactory Bulb Neurons in Parkinson's Disease60%
related📖Substantia Nigra Pars Compacta Dopamine Neurons in Parkinson60%
related📖GPR6 Modulator Therapy for Parkinson's Disease60%
related📖SIRT1 Activators for Parkinson's Disease60%
related📖Ethnicity-Specific Genetic Architecture Hypothesis in Parkin60%
related📖Dopamine D3 and D4 Receptor Selective Agonists for Parkinson60%
related📖Mitochondria-Lysosome Contact Site Dysfunction in Parkinson&60%
related📖MDS 2026 — Parkinson's Disease Clinical Advances60%
related📖Adaptive Deep Brain Stimulation to Offset STN Dysregulation 60%
related📖Parkinson's Disease Assessment Scales60%
related📖Nelotanserin for Parkinson's Disease Psychosis60%
related📖GBA Pathway in Parkinson's Disease60%
related📖Immune Drug Repurposing for Advanced Parkinson's Diseas60%
related📖Probiotic Treatment for Depression in Parkinson's Disea60%
related📖International Parkinson's Disease Genomics Consortium (60%
related📖Parkinson's Disease Circadian Rhythm Dysfunction Therap60%
related📖Parkinson's Disease Synaptic Repair and Preservation Co60%
related📖DJ-1 Oxidative Stress Response Pathway in Parkinson's D60%
related📖Ion Channel Dysfunction in Parkinson's Disease60%
related📖ATP13A2/PARK9 Lysosomal Function Therapies for Parkinson60%
related📖Sigma-1 Receptor Agonists for Parkinson's Disease60%
related📖Taiwanese Biotechnology Companies in Parkinson's Diseas60%
related📖Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%
related📖Purinergic Receptor Targeted Trials in Parkinson's Dise60%
related📖Gut-First vs Brain-First Alpha-Synuclein Propagation in Park60%
related📖CRISPRi Epigenetic Silencing of SNCA for Parkinson's Di60%
related📖GBA1 Gaucher Disease Modulator for Parkinson's Disease60%
related📖Speech Therapy for Parkinson's Disease60%
related📖Autologous Stem Cell-Derived Dopaminergic Neurons for Parkin60%
related📖Neurovascular Unit Function Assessment in Parkinson's D60%
related📖VTA Dopamine Neurons in Parkinson's Disease60%
related📖Parkinson's Disease Lysosomal and Autophagy Companies60%
related📖LRRK2 Antisense Oligonucleotide Therapies for Parkinson'60%
related📖TFEB Activators for Parkinson's Disease60%
related📖Integrin Signaling in Parkinson's Disease60%
related📖Microbiome-Gut-Brain Axis in Parkinson's Disease60%
related📖D2 Striatal Medium Spiny Neurons in Parkinson's Disease60%
related📖DNA Damage Response in Parkinson's Disease60%
related📖Nigral Glia in Parkinson's Disease60%
related📖Neuroinflammation in Parkinson's Disease60%
related📖Photoreceptor Cells in Parkinson's Disease60%
related📖Inosine — Urate Elevation Therapy for Parkinson's Disea60%
related📖Metal Ion Homeostasis in Parkinson's Disease60%
related📖Psilocybin Therapy for Depression in Parkinson's Diseas60%
related📖VPS35/Retromer Stabilizers for Parkinson's Disease60%
related📖Theta Deep Brain Stimulation for Cognitive Enhancement in Pa60%
related📖PINK1/PARKIN Mitophagy Activators for Parkinson's Disea60%
related📖Causal vs Reactive Neuroinflammation in Parkinson's Dis60%
related📖NURR1 Agonists for Parkinson's Disease60%
related📖Synaptic Plasticity Therapeutics for Parkinson's Diseas60%
related📖CUE1 Device for Parkinson's Disease (NCT06174948)60%
related📖cGAS-STING Pathway Validation Study in Parkinson's Dise60%
related📖Alpha-Synuclein Antisense Therapy for Parkinson's Disea60%
related📖Parkinson's Disease Neuroimaging Initiative (PDNI)60%
related📖Levodopa for Parkinson's Disease — Investment Landscape60%
related📖FGF Signaling in Parkinson's Disease60%
related📖Hsp90 Inhibitors for Parkinson's Disease60%
related📖MicroRNA Therapy for Parkinson's Disease60%
related📖Enteric Glial Cells in Parkinson's Disease60%
related📖Dance Movement Therapy for Parkinson's Disease60%
related📖Silymarin for Neuroprotection and Symptom Management in Park60%
related📖Cognitive Rehabilitation for Parkinson's Disease60%
related📖HIF/Hypoxia Signaling in Parkinson's Disease60%
related📖Metal Ion-Synuclein-Mitochondria (MISM) Axis in Parkinson&#x60%
related📖PARK7/DJ-1 Neuroprotection Pathway — Parkinson's Diseas60%
related📖Pallido-Thalamocortical Motor Pathway in Parkinson's Di60%
related📖5-Hydroxymethylcytosine (5-hmC) as a Biomarker for Parkinson60%
related📖Neurovascular Unit Dysfunction Hypothesis in Parkinson'60%
related📖Dopaminergic Substantia Nigra Neurons in Parkinson's Di60%
related📖Peroxisomal Dysfunction Validation in Parkinson's Disea60%
related📖Neuro-immune Interactome in Parkinson's Disease (NCT07060%
related📖Self-administered tDCS for Parkinson's Disease Gait60%
related📖GBA Glucocerebrosidase Dysfunction and Parkinson's Dise60%
related📖Gut-Immune-Brain Axis Clinical Trial for Parkinson's Di60%
related📖DREADDs Therapy for Parkinson's Disease60%
related📖Calcium Signaling Dysregulation in Parkinson's Disease60%
related📖CVN424 Phase 3 ARISE Trial for Parkinson's Disease60%
related📖MAO-B Inhibitors for Parkinson's Disease — Investment L60%
related📖NAD+ Precursors (NMN/NR) for Parkinson's Disease60%
related📖Focused Ultrasound for Parkinson's Disease60%
related📖Ferroptosis Therapy for Parkinson's Disease60%
related📖ACI-7104.056 Alpha-Synuclein Vaccine for Parkinson's Di60%
related📖Chemokine Receptor Modulation for Parkinson's Disease60%
related📖MPTP Parkinson's Disease Model60%
related📖Hypoxia Neuroprotection in Sporadic Parkinson's Disease60%
related📖AAN 2026 — Parkinson's Disease60%
related📖Amino Acid Supplement in Parkinson's Disease (NCT06954660%
related📖Spinal Cord Stimulation (SCS) for Parkinson's Disease60%
related📖Anesthesia Choice in STN-DBS for Parkinson's Disease (N60%
related📖MSA Glial Pathology — Detailed Comparison with Parkinson60%
related📖Epigenetic Dysregulation Hypothesis in Parkinson's Dise60%
related📖Physical Activity Effects on Mitochondrial Function in Parki60%
related📖Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%
related📖Parkinson's Disease EGFR Signaling Therapy Companies60%
related📖NIH Parkinson's Disease Repurposing Program60%
related📖Raphe Nucleus Serotonergic Neurons in Parkinson's Disea60%
related📖MDS 2026 — Emerging Therapeutics in Parkinson's Disease60%
related📖Osteopathic Manipulative Medicine for Parkinson's Disea60%
related📖TLR Signaling in Parkinson's Disease60%
related📖6-OHDA Rat Model of Parkinson's Disease60%
related📖International Parkinson's Disease Genetics Consortium60%
related📖MLCS Quantification Methods in Parkinson's Disease Rese60%
related📖Neurovascular Unit Dysfunction in Parkinson's Disease60%
related📖tDCS + Nordic Walking for Parkinson's Disease Motor Sym60%
related📖NURR1 Agonist Therapy for Parkinson's Disease60%
related📖NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
related📖Endocannabinoid System Dysfunction Validation in Parkinson&#60%
related📖LRRK2 Transgenic Mouse Model for Parkinson's Disease60%
related📖Bemdaneprocel for Parkinson's Disease60%
related📖Notch and Gamma-Secretase Modulators for Parkinson's Di60%
related📖LRRK2 Inhibitors for Parkinson's Disease60%
related📖H₂S-Releasing Compounds Therapy for Parkinson's Disease60%
related📖Gut Microbiome-Derived Lipids and Alpha-Synuclein Aggregatio60%
related📖Social Behaviors and Quality of Life in Parkinson's Dis60%
related📖FBXO7→Mitophagy Dysfunction→Parkinson's Disease Causal 60%
related📖LRRK2 Pathway in Parkinson's Disease60%
related📖Astrocyte-Targeted Parkinson's Disease Therapies60%
related📖Blood Microbial Signatures in Parkinson's Disease60%
related📖Ultrasonographic Respiratory Muscle Assessment in Parkinson&60%
related📖NF-κB Signaling in Parkinson's Disease60%
related📖Circadian Dysregulation in Parkinson's Disease60%
related📖ATP13A2 Lysosomal Dysfunction Pathway in Parkinson's Di60%
related📖Purinergic Signaling Dysfunction Hypothesis in Parkinson60%
related📖Neuroinflammation in [Parkinson's Disease](/diseases/pa60%
related📖Substantia Nigra Pars Compacta Dopamine Neurons in Parkinson60%
related📖Environmental Toxins and Parkinson's Disease Risk60%
related📖TMEM175 Lysosomal Overflow Valve in Parkinson's Disease60%
related📖NCT06530290: Mirtazapine for Anxiety in Parkinson's Dis60%
related📖Selective Vulnerability of Substantia Nigra Dopaminergic Neu60%
related📖Botulinum Toxin for Parkinson's Disease60%
related📖Mitochondrial Dynamics Modulators for Parkinson's Disea60%
related📖LRRK2 Kinase Pathway in Parkinson's Disease60%
related📖CUE1 Non-Invasive Vibrotactile Device for Parkinson's D60%
related📖Lipid Raft Modulation for Parkinson's Disease Therapeut60%
related📖Accelerating Medicines Partnership for Parkinson's Dise60%
related📖Pedunculopontine Nucleus Cholinergic Neurons in Parkinson&#x60%
related📖Axonal Transport Dysfunction Validation in Parkinson's 60%
related📖Transcutaneous Vagal Nerve Stimulation (tVNS) for Parkinson&60%
related📖IRL757 for Parkinson's Disease Apathy60%
related📖PI3K/Akt Signaling in Parkinson's Disease60%
related📖Ferroptosis Hypothesis in Parkinson's Disease60%
related📖Rehabilitation Robotics for Parkinson's Disease60%
related📖International Congress on Parkinson's Disease60%
related📖Epigenetic Dysregulation Validation in Parkinson's Dise60%
related📖GPR65 (TDAG8) Modulator Therapy for Parkinson's Disease60%
related📖Dopamine Transporters in Parkinson's Disease60%
related📖Tissue Engineered Nigrostriatal Pathway for Parkinson's60%
related📖Non-Dopaminergic Neurotransmitter Degeneration as Upstream D60%
related📖Ubiquitin-Proteasome System Therapeutic Companies for Parkin60%
related📖Calcium Channel Dysfunction in Parkinson's Disease60%
related📖Gap Junction Dysfunction Validation in Parkinson's Dise60%
related📖Astrocytes in Parkinson's Disease Neurodegeneration60%
related📖Lithium for Parkinson's Disease - SUNY Buffalo Trial (N60%
related📖Phosphodiesterase Inhibitors for Parkinson's Disease60%
related📖Synaptic Vesicle Trafficking in Parkinson's Disease60%
related📖GSK3 Signaling in Parkinson's Disease60%
mentions📖hypotheses60%
related📖Synaptic Vesicle Trafficking Pathway in Parkinson's Dis60%
related📖GBA Gene Mutations and Parkinson's Disease Risk60%
related📖HRG2010 for Parkinson's Disease With Motor Fluctuations60%
mentions📖mechanisms60%
related📖Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%
related📖Mindfulness Meditation for Parkinson's Disease60%
related📖CRISPR Gene Editing for Parkinson's Disease60%
related📖Astrocyte Dysfunction in Parkinson's Disease60%
related📖FMT for Parkinson's Disease60%
related📖ASO Therapy for Parkinson's Disease60%
related📖Digital Therapeutic Platform for Swallowing and Drooling Pro60%
related📖Kenai RNDP-001 Dopaminergic Progenitor Cell Therapy for Park60%
related📖Parkin Activators for Parkinson's Disease60%
related📖PINK1/Parkin Pathway in Parkinson's Disease60%
related📖Parkinson's Disease Digital Therapeutics Companies60%
related📖GBA Gene Therapy for Parkinson's Disease60%
related📖Dorsal Raphe Serotonergic Neurons in Parkinson's Diseas60%
related📖CSF1R Inhibitors for Parkinson's Disease60%
related📖GBA Glucocerebrosidase Endolysosomal Pathway in Parkinson&#x60%
related📖UCHL1 (PARK5) Pathway in Parkinson's Disease60%
related📖GT-02287 for Parkinson's Disease60%
related📖VA Parkinson's Disease Research Program60%
related📖TB006 Phase 2a Parkinson's Disease Trial (NCT06773962)60%
related📖Endocannabinoid System Dysfunction Hypothesis in Parkinson&#60%
related📖Cepharanthine (千金藤素) - Investigational Therapy for Parkinson60%
related📖Alpha-Synuclein Seed Kinetic Staging in Parkinson's Dis60%
related📖Dopamine Transporter (DAT) Dysfunction Pathway in Parkinson&60%
related📖TREM2 in Parkinson's Disease — Cross-Disease Therapeuti60%
related📖Sirtuin Dysfunction Validation in Parkinson's Disease60%
related📖Astrocyte Iron Metabolism and Alpha-Synuclein Pathology in P60%
related📖Epigenetic Regulation Dysfunction in Alzheimer's and Pa60%
related📖Entorhinal Cortex in Parkinson's Disease60%
related📖MDS 2026 — Genetic Parkinson's Disease Research Summary60%
related📖Non-Dopaminergic Neurotransmitter System Degeneration Hypoth60%
related📖MDS 2026 — Motor Complications in Parkinson's Disease60%
related📖Multi-Analyte Biomarker Panel for Parkinson's Disease D60%
related📖Genetic Penetrance Factors in Parkinson's Disease60%
mentions📖alpha-synuclein60%
related📖Pallido-thalamocortical Motor Pathway in Parkinson's Di60%
related📖Mitochondria-Lysosome Contact Sites Dysfunction in Parkinson60%
related📖Sigma-1 Receptor (SIGMAR1) Signaling in Parkinson's Dis60%
related📖DJ-1/PARK7 Neuroprotection Pathway in Parkinson's Disea60%
related📖Autologous iNSC-DAP Cell Therapy for Parkinson's Diseas60%
related📖Enteric Neurons in Parkinson's Disease60%
related📖MPTP Mouse Model of Parkinson's Disease60%
related📖Dopamine Agonists - Parkinson's Disease Treatment60%
related📖Whole-Body Photobiomodulation for Motor and Cognitive Change60%
related📖Microglia in Parkinson's Disease Substantia Nigra60%
related📖SGLT2 Inhibitors for Parkinson's Disease60%
related📖iPSC Therapy for Parkinson's Disease60%
mentions📖neuroimaging60%
related📖Terazosin for Cardiac Autonomic Changes in Early Parkinson&#60%
related📖Parkinson's Disease Synaptic Dysfunction Therapeutic Co60%
mentions📖events60%
related📖VPS35/Retromer Stabilizers for Parkinson's Disease60%
related📖EC5026 (STEP Study) - Parkinson's Disease Clinical Tria60%
related📖Clinical Trials in Parkinson's Disease60%
related📖cGAS-STING Signaling in Parkinson's Disease60%
related📖BCI Therapy for Parkinson's Disease60%
related📖Stress Granule Dysfunction Hypothesis in Parkinson's Di60%
related📖Nucleus Accumbens in Parkinson's Disease60%
related📖Tuberoinfundibular Dopamine Neurons in Parkinson's Dise60%
related📖Amygdala Neurons in Parkinson's Disease60%
related📖Synuclein Pathway in Parkinson's Disease60%
related📖Ropinirole - Dopamine Agonist for Parkinson's Disease60%
related📖LRRK2 Signaling Pathway in Parkinson's Disease60%
related📖Pain in Parkinson's Disease: Exploration of the Seroton60%
related📖Extracellular Vesicles in Parkinson's Disease60%
related📖Parkinson's Disease Iron Chelation Therapy Companies60%
related📖Enteric Neurons in Parkinson's Disease60%
related📖Mitochondrial Dynamics Dysfunction Hypothesis in Parkinson&#60%
related📖Combination Therapy Sequencing in Parkinson's Disease60%
related📖CSF Cytokine Profiles as Parkinson's Disease Biomarkers60%
related📖PSAP-GPR37-IL-6 Axis in Parkinson's Disease60%
related📖Regulated Necrosis Hypothesis in Parkinson's Disease60%
related📖Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
related📖Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%
related📖Nilotinib for Parkinson's Disease60%
related📖ABBV-951 Subcutaneous Infusion for Parkinson's Disease60%
related📖ATP13A2 (PARK9) Pathway in Parkinson's Disease60%
related📖Vutiglabridin for Parkinson's Disease60%
related📖Caregiver Support and Palliative Care in Atypical [Parkinson60%
related📖Circadian Rhythm Dysfunction in Parkinson's Disease60%
related📖Melanocytes in Parkinson's Disease60%
related📖Edmond J Safra Accelerating Clinical Trials in Parkinson60%
related📖Prodromal Parkinson's Disease60%
related📖Peroxisome Dysfunction Hypothesis in Parkinson's Diseas60%
related📖ATP13A2 Lysosomal Dysfunction Parkinson's Disease Causa60%
related📖Protein Kinase C (PKC) Signaling in Parkinson's Disease60%
related📖Substantia Nigra Pars Compacta in Parkinson's Disease60%
related📖ER Stress and Unfolded Protein Response in Parkinson's 60%
mentions📖experiments60%
related📖VPS35/Retromer Pathway in Parkinson's Disease60%
related📖Parkinson's Disease Investment Landscape60%
related📖Continuous Glucose Monitoring for Parkinson's Disease60%
related📖Ferroptosis in Parkinson's Disease60%
related📖Circuit-Based DBS for Parkinson's Disease (NCT05658302)60%
related📖Nilotinib for Parkinson's Disease (NCT03744468)60%
related📖Pexidartinib (PLX3397) CSF1R Inhibitor Parkinson's Dise60%
related📖cGAS-STING Inhibitors for Parkinson's Disease60%
related📖PARK19 (DNAJC6-Related Parkinson's Disease)60%
related📖NLRP3 Inflammasome Modulation for Parkinson's Disease60%
related📖TrkB Modulator Therapy for Parkinson's Disease60%
related📖Urolithin A for Parkinson's Disease (MUSIC Trial NCT06060%
related📖Dementia with Lewy Bodies vs Parkinson's Disease Compar60%
related📖Prodromal Parkinson's Disease Biomarker Development — E60%
related📖Nigral Astrocytes in Parkinson's Disease60%
related📖Vulnerable Dopaminergic Neurons in Parkinson's Disease60%
related📖PDLIM7 Epigenetic Activation in Parkinson's Disease60%
related📖Subthalamic Nucleus in Parkinson's Disease60%
related📖LRRK2 Signaling Pathway in Parkinson's Disease60%
related📖DLB, Parkinson's Disease, and Alzheimer's Disease:60%
related📖Polygenic Risk Score Integration Panel for Alzheimer's 60%
related📖PROTAC Therapy for Parkinson's Disease60%
related📖Epigenetics in Parkinson's Disease60%
related📖Gap Junction Dysfunction Hypothesis in Parkinson's Dise60%
related📖Exergaming With Physical Objects for Upper Limb Rehabilitati60%
related📖Parkinson's Disease Treatment Options60%
related📖Interpeduncular Nucleus Cholinergic Neurons in Parkinson60%
related📖Nurr1 (NR4A2) Pathway in Parkinson's Disease60%
related📖Ubiquitin-Proteasome System Dysfunction in Parkinson's 60%
related📖Neuroinflammation in Parkinson's Disease Dementia and D60%
related📖Parkinson's Disease Dementia (PDD)60%
related📖Glymphatic-Circadian Axis Dysfunction Hypothesis in Parkinso60%
related📖Parkinson's Disease Genetic Variants60%
related📖Dopaminergic VTA Neurons in Parkinson's Disease60%
related📖Sirtuin Modulator Companies for Parkinson's Disease60%
related📖Alpha-Synuclein Aggregation Pathway in Parkinson's Dise60%
related📖Mitochondria-Lysosome Contact Site (MLCS) Dysfunction Hypoth60%
related📖Axonal Transport Dysfunction Hypothesis in Parkinson's 60%
related📖Pramipexole - Dopamine Agonist for Parkinson's Disease60%
related📖Nigrostriatal Dopamine Terminals in Parkinson's Disease60%
related📖Non-Motor Symptom Progression in Parkinson's Disease — 60%
related📖Alpha-Synuclein Propagation Pathway in Parkinson's Dise60%
related📖Clinical Efficacy and Mechanism of tDCS for Dysphagia in Par60%
related📖GWAS Findings Hub: Alzheimer's and Parkinson's Dis60%
related📖NLRP3 Inflammasome Hypothesis in Parkinson's Disease60%
related📖FGF13-MTCH2 Neuroprotection in Parkinson's Disease60%
related📖Cionic Neural Sleeve for Parkinson's Disease (NCT07284860%
related📖Parkinson's Disease Protein Kinase C Modulator Companie60%
related📖Substantia Nigra Pars Reticulata Neurons in Parkinson's60%
related📖Age-Sensitive Cortical Vulnerability in Parkinson's Dis60%
related📖Local Field Potentials of Subthalamic Nucleus in Parkinson&#60%
related📖Sirtuin Pathway Dysfunction Hypothesis in Parkinson's D60%
related📖A53T Alpha-Synuclein Transgenic Mouse Model of Parkinson60%
related📖Mesolimbic Dopamine Pathway Neurons in Parkinson's Dise60%
mentions📖Parkinson's Disease Subtypes55%
mentions📖Investment Landscape: Parkinson's Disease55%
mentions📖Dementia with Lewy Bodies vs Parkinson's Disease Compar55%
mentions📖Prodromal Parkinson's Disease55%
mentions📖ATP13A9 and Parkinson's Disease55%
mentions📖Caregiver Support and Palliative Care in Atypical [Parkinson55%
mentions📖Alzheimer's Disease vs Parkinson's Disease Compari55%
mentions📖Parkinson's Disease Dementia (PDD)55%
mentions📖Parkinson's Disease Genetic Variants55%
mentions📖DLB, Parkinson's Disease, and Alzheimer's Disease:55%
mentions📖PARK19 (DNAJC6-Related Parkinson's Disease)55%
mentions📖Gut-First vs Brain-First Parkinson's Disease Trajectori55%
related📖Parkinson's Disease Hypothesis Rankings54%
related📖Pexidartinib (PLX3397) CSF1R Inhibitor Parkinson's Dise54%
related📖Portable Exoskeleton for Parkinson's Disease Mobility (54%
related📖Laterodorsal Tegmental Nucleus Cholinergic Neurons in Parkin54%
related📖ARC-IM Adaptive Neurostimulation for Parkinson's Diseas54%
related📖CRISPR Gene Editing for Parkinson's Disease54%
related📖PI3K/Akt Activator Clinical Trials for Parkinson's Dise54%
related📖Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%
related📖NLRP3 Inflammasome Validation Study in Parkinson's Dise54%
related📖UCHL1 (PARK5) Pathway in Parkinson's Disease54%
related📖PARK7/DJ-1 Neuroprotection Pathway — Parkinson's Diseas54%
related📖Regulated Necrosis Hypothesis in Parkinson's Disease54%
related📖Wearable Technologies for Parkinson's Disease54%
related📖Olfactory Ensheathing Cells in Parkinson's Disease54%
related📖TLR Signaling in Parkinson's Disease54%
related📖Parkinson's Disease Genetic Variants54%
related📖Mitochondrial Dynamics Modulators for Parkinson's Disea54%
related📖Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%
related📖Parkinson's Disease Mitochondrial Neuroprotection Compa54%
related📖Glial-Neuron Crosstalk in Parkinson's Disease54%
related📖Non-Motor Symptoms Treatment in Parkinson's Disease54%
related📖CUE1 Device for Parkinson's Disease (NCT06174948)54%
related📖Parkinson's Disease Biomarkers54%
related📖Peroxisomal Dysfunction Validation in Parkinson's Disea54%
related📖Autologous Stem Cell-Derived Dopaminergic Neurons for Parkin54%
related📖PINK1-Parkin Mitophagy Pathway in Parkinson's Disease54%
related📖Dorsal Raphe Serotonergic Neurons in Parkinson's Diseas54%
related📖GBA1 Gaucher Disease Modulator for Parkinson's Disease54%
related📖Parkinson's Disease HIF/Hypoxia Signaling Therapy Compa54%
related📖Dopamine Agonists - Parkinson's Disease Treatment54%
related📖Nigral Astrocytes in Parkinson's Disease54%
related📖6-OHDA Rat Model of Parkinson's Disease54%
related📖Pedunculopontine Nucleus in Parkinson's Disease54%
related📖Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%
related📖FBXO7→Mitophagy Dysfunction→Parkinson's Disease Causal 54%
related📖PDLIM7 Epigenetic Activation in Parkinson's Disease54%
related📖Hsp90 Inhibitors for Parkinson's Disease54%
related📖Biomarkers for Parkinson's Disease54%
related📖MDS 2026 — Parkinson's Disease Clinical Advances54%
related📖PI3K-Akt Signaling in Parkinson's Disease54%
related📖DNA Damage Repair Deficiency Validation Study in Parkinson&#54%
related📖Mitochondrial Failure Nodes in Parkinson's Disease54%
related📖PINK1/PARKIN Mitophagy Activators for Parkinson's Disea54%
related📖Clinical Efficacy and Mechanism of tDCS for Dysphagia in Par54%
related📖ER Stress and Unfolded Protein Response in Parkinson's 54%
related📖Blood Microbial Signatures in Parkinson's Disease54%
related📖cGAS-STING Pathway Dysregulation Hypothesis in Parkinson54%
related📖Substantia Nigra Pars Compacta Dopamine Neurons in Parkinson54%
related📖Continuous Glucose Monitoring for Parkinson's Disease54%
related📖Mitochondrial Dysfunction in Parkinson's Disease54%
related📖Anthony Lang — PSP and Parkinson's Disease Researcher54%
related📖DNA Damage Response in Parkinson's Disease54%
related📖Peroxisome Dysfunction Validation in Parkinson's Diseas54%
related📖PARK7 (DJ-1) Targeted Therapy for Parkinson's Disease54%
related📖LRRK2 Kinase Pathway in Parkinson's Disease54%
related📖Substantia Nigra Pars Compacta in Parkinson's Disease54%
related📖Nigrostriatal Dopamine Terminals in Parkinson's Disease54%
related📖Gap Junction Dysfunction Validation in Parkinson's Dise54%
related📖Resilient Neurons in Parkinson's Disease54%
related📖GBA Glucocerebrosidase Dysfunction and Parkinson's Dise54%
related📖Anesthesia Choice in STN-DBS for Parkinson's Disease (N54%
related📖Axonal Transport Dysfunction Validation in Parkinson's 54%
related📖ACI-7104.056 Alpha-Synuclein Vaccine for Parkinson's Di54%
related📖NLRP3 Inflammasome Inhibitors for Parkinson's Disease54%
related📖NCT05565443: MR-Guided Focused Ultrasound + GCase for Parkin54%
related📖LRRK2 Antisense Oligonucleotide Therapies for Parkinson'54%
related📖BIA 28-6156 for GBA-Parkinson's Disease54%
related📖Ginsenosides Neuroprotection in Parkinson's Disease54%
related📖Parkinson's Disease Synaptic Dysfunction Therapeutic Co54%
related📖Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
related📖Astrocyte Iron Metabolism and Alpha-Synuclein Pathology in P54%
related📖MDS 2026: Surgical Therapies for Parkinson's Disease54%
related📖Metal Ion-Synuclein-Mitochondria (MISM) Axis in Parkinson&#x54%
related📖GPR6 Modulator Therapy for Parkinson's Disease54%
related📖HIF/Hypoxia Signaling in Parkinson's Disease54%
related📖MDS 2026 — Genetic Parkinson's Disease Research Summary54%
related📖CVN424 Phase 3 Trial for Parkinson's Disease54%
related📖AMPK Activators for Parkinson's Disease54%
related📖siRNA Therapy for Parkinson's Disease54%
related📖LRRK2 Signaling Pathway in Parkinson's Disease54%
related📖Enteric Neurons in Parkinson's Disease54%
related📖MDS 2026: Neuroprotection and Neurorestorative Strategies fo54%
related📖GLP-1 Receptor Agonists for Parkinson's Disease54%
related📖Dietary Interventions for Parkinson's Disease54%
related📖Autologous iNSC-DAP Cell Therapy for Parkinson's Diseas54%
related📖Notch Signaling in Parkinson's Disease54%
related📖Glymphatic Waste Clearance Therapy for Parkinson's Dise54%
related📖LRRK2 Transgenic Mouse Model for Parkinson's Disease54%
related📖CR3-Dependent Microglial Synapse Elimination in Parkinson&#x54%
related📖Parkinson's Disease ER Stress/UPR Modulator Companies54%
related📖Fasudil for Parkinson's Disease (ROCK-PD)54%
related📖Sirtuin Dysfunction Validation in Parkinson's Disease54%
related📖LY4006896 Phase 1 Parkinson's Disease Trial54%
related📖Lithium for Parkinson's Disease - SUNY Buffalo Trial (N54%
related📖Macroautophagy Dysfunction Validation Framework in Parkinson54%
related📖Parkinson's Disease Protein Kinase C Modulator Companie54%
related📖Stress Granule Dysfunction Hypothesis in Parkinson's Di54%
related📖HIF/Hypoxia Signaling in Parkinson's Disease54%
related📖Probiotic and Microbiome Therapy for Parkinson's Diseas54%
related📖Transcutaneous Vagal Nerve Stimulation (tVNS) for Parkinson&54%
related📖Botulinum Toxin for Parkinson's Disease54%
related📖Neuroinflammation in [Parkinson's Disease](/diseases/pa54%
related📖experiments54%
related📖Amygdala Neurons in Parkinson's Disease54%
related📖JAK-STAT Signaling in Parkinson's Disease54%
related📖Parkinson's Disease Neuroimaging Initiative (PDNI)54%
related📖Pallido-Thalamocortical Motor Pathway in Parkinson's Di54%
related📖Chemokine Receptor Modulation for Parkinson's Disease54%
related📖Enteric Neurons in Parkinson's Disease54%
related📖Dorsal Raphe in Parkinson's Disease54%
related📖Substantia Nigra Pars Reticulata Neurons in Parkinson's54%
related📖Digital Diagnostic Devices for Parkinson's Disease (NCT54%
related📖GBA Gene Therapy for Parkinson's Disease54%
related📖International Congress on Parkinson's Disease54%
related📖DJ-1/PARK7 Neuroprotection Pathway in Parkinson's Disea54%
related📖Vulnerable Dopaminergic Neurons in Parkinson's Disease54%
related📖Rehabilitation Robotics for Parkinson's Disease54%
related📖Terazosin for Cardiac Autonomic Changes in Early Parkinson&#54%
related📖Oligodendrocyte-Myelin Dysfunction Hypothesis in Parkinson&#54%
related📖Multi-Ethnic Parkinson's Disease GWAS54%
related📖Enteric Nervous System Neurons in Parkinson's Disease54%
related📖VPS35/Retromer Pathway in Parkinson's Disease54%
related📖Mitochondria-Lysosome Contact Sites Dysfunction in Parkinson54%
related📖EC5026 (STEP Study) Phase 1 Parkinson's Disease Trial (54%
related📖Spinal Cord Stimulation for Freezing of Gait in Parkinson&#x54%
related📖DBS for Visuomotor Function in Parkinson's Disease (NCT54%
related📖Neurorestore Therapies for Parkinson's Disease54%
related📖ABBV-951 Subcutaneous Infusion for Parkinson's Disease54%
related📖Cav1.3 Calcium Channel Modulators for Parkinson's Disea54%
related📖TB006 for Parkinson's Disease54%
related📖Continuous Dopaminergic Stimulation for Parkinson's Dis54%
related📖Self-administered tDCS for Parkinson's Disease Gait54%
related📖DREADDs Therapy for Parkinson's Disease54%
related📖PARK19 (DNAJC6-Related Parkinson's Disease)54%
related📖EGFR Signaling in Parkinson's Disease54%
related📖MAO-B Inhibitors for Parkinson's Disease — Investment L54%
related📖Parkinson's Disease Lysosomal and Autophagy Companies54%
related📖International Parkinson's Disease Genomics Consortium (54%
related📖iPSC Therapy for Parkinson's Disease54%
related📖Dance Movement Therapy for Parkinson's Disease54%
related📖Intranasal Therapy for Parkinson's Disease54%
related📖Epigenetic Therapies for Parkinson's Disease54%
related📖Theta-Firing Dopamine Neurons in Parkinson's Disease54%
related📖Parkinson's Disease Subtype Classification — Precision 54%
related📖Parkinson's Disease Assessment Scales54%
related📖biomarkers54%
related📖Integrin Signaling in Parkinson's Disease54%
related📖Age-Sensitive Cortical Vulnerability in Parkinson's Dis54%
related📖Urolithin A for Parkinson's Disease (MUSIC Trial NCT06054%
related📖Neurturin (NRTN) Therapy for Parkinson's Disease54%
related📖Clinical Trials in Parkinson's Disease54%
related📖Morris K. Udall Centers for Parkinson's Disease Researc54%
related📖Gut-First vs Brain-First Alpha-Synuclein Propagation in Park54%
related📖Peripheral Immune System in Parkinson's Disease54%
related📖Vesicular Monoamine Transporter (VMAT) Modulators for Parkin54%
related📖MicroRNA Therapy for Parkinson's Disease54%
related📖Mitochondrial Dynamics Modulators for Parkinson's Disea54%
related📖TrkB Modulator Therapy for Parkinson's Disease54%
related📖Deep Brain Stimulation for Parkinson's Disease54%
related📖Enteric Neurons in Parkinson's Disease54%
related📖Lipid Raft Modulation for Parkinson's Disease Therapeut54%
related📖STING-CASM-GABARAP-LRRK2 Pathway in Parkinson's Disease54%
related📖BCI Therapy for Parkinson's Disease54%
related📖Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%
related📖Alzheimer's Disease vs Parkinson's Disease Compari54%
related📖GPR68 (OGR1) Modulator Therapy for Parkinson's Disease54%
related📖ATP13A2 Lysosomal Dysfunction Pathway in Parkinson's Di54%
related📖ABBV-951 (foslevodopa/foscarbidopa) for Parkinson's Dis54%
related📖NF-κB Signaling in Parkinson's Disease54%
related📖Causal vs Reactive Neuroinflammation in Parkinson's Dis54%
related📖Multi-Analyte Biomarker Panel for Parkinson's Disease D54%
related📖MDS 2026 — Precision Medicine in Parkinson's Disease54%
related📖Synaptic Vesicle Trafficking Pathway in Parkinson's Dis54%
related📖NUS1 CoQ10 Pathway Modulation for Parkinson's Disease54%
related📖Thoracic Epidural SCS for Parkinson's Disease Freezing 54%
related📖tDCS + Nordic Walking for Parkinson's Disease Motor Sym54%
related📖GWAS Findings Hub: Alzheimer's and Parkinson's Dis54%
related📖Sirtuin Pathway Dysfunction Hypothesis in Parkinson's D54%
related📖Parkinson's Disease Drug Repurposing Consortia54%
related📖NURR1 Agonists for Parkinson's Disease54%
related📖Parkinson's Disease Iron Chelation Therapy Companies54%
related📖UCHL1 Ubiquitin-Proteasome Parkinson's Disease Causal C54%
related📖Acupuncture Therapy for Parkinson's Disease54%
related📖Ropinirole - Dopamine Agonist for Parkinson's Disease54%
related📖Cellular Senescence Hypothesis in Parkinson's Disease54%
related📖Purinergic Signaling Dysfunction Hypothesis in Parkinson54%
related📖Sirtuin Modulators for Parkinson's Disease54%
related📖Speech Therapy for Parkinson's Disease54%
related📖Genetic Penetrance Factors in Parkinson's Disease54%
related📖MDS 2026 — Freezing of Gait and Postural Instability in Park54%
related📖Caregiver Support and Palliative Care in Atypical [Parkinson54%
related📖Nelotanserin for Parkinson's Disease Psychosis54%
related📖Levodopa for Parkinson's Disease — Investment Landscape54%
related📖Pramipexole - Dopamine Agonist for Parkinson's Disease54%
related📖Digital Biomarker Platforms for Parkinson's Disease54%
related📖Dental Health and Oral Microbiome in Parkinson's Diseas54%
related📖Purinergic Signaling Dysfunction Validation in Parkinson54%
related📖NLRP3 Inhibitors in Parkinson's Disease: Research and C54%
related📖Ambroxol for Parkinson's Disease54%
related📖Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%
related📖Exercise as Treatment of Fatigue in Parkinson's Disease54%
related📖PROTAC Therapy for Parkinson's Disease54%
related📖Hypoxia Neuroprotection in Sporadic Parkinson's Disease54%
related📖Parkinson's Disease VEGF/Angiogenic Signaling Therapy C54%
related📖A53T Alpha-Synuclein Transgenic Mouse Model of Parkinson54%
related📖Inosine — Urate Elevation Therapy for Parkinson's Disea54%
related📖VPS35 Retromer Dysfunction Parkinson's Disease Causal C54%
related📖Nilotinib for Parkinson's Disease (NCT03744468)54%
related📖PARK16 - Parkinson's Disease Locus 1654%
related📖Mixed Pathology Effects on Parkinson's Disease Progress54%
related📖CSF Cytokine Profiles as Parkinson's Disease Biomarkers54%
related📖Synuclein Pathway in Parkinson's Disease54%
related📖Coenzyme Q10 for Parkinson's Disease54%
related📖NRF2 Activators for Parkinson's Disease54%
related📖Peroxisomal Dysfunction Hypothesis in Parkinson's Disea54%
related📖Parkinson's Disease Ferroptosis Companies54%
related📖Circuit-Based DBS for Parkinson's Disease (NCT05658302)54%
related📖Autonomic Dysfunction in Parkinson's Disease54%
related📖DLB, Parkinson's Disease, and Alzheimer's Disease:54%
related📖Metformin for Parkinson's Disease - Phase 2/3 Trial (NC54%
related📖Ion Channel Dysfunction in Parkinson's Disease54%
related📖Mitochondria-Lysosome Contact Sites in Parkinson's Dise54%
related📖Apocynin for Parkinson's Disease54%
related📖Valacyclovir for HSV-1-Positive Parkinson's Disease54%
related📖Neurotrophic Factor Signaling in Parkinson's Disease54%
related📖DJ-1 Oxidative Stress Response Pathway in Parkinson's D54%
related📖Parkinson's Disease Circadian Rhythm Dysfunction Therap54%
related📖Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%
related📖Amino Acid Supplementation in Parkinson's Disease54%
related📖Dopaminergic Substantia Nigra Neurons in Parkinson's Di54%
related📖Molecular Hydrogen Therapy for Parkinson's Disease54%
related📖Parkinson's Disease EGFR Signaling Therapy Companies54%
related📖Immune Drug Repurposing for Advanced Parkinson's Diseas54%
related📖Nurr1 (NR4A2) Pathway in Parkinson's Disease54%
related📖Substantia Nigra Pars Compacta Dopamine Neurons in Parkinson54%
related📖NouvNeu001 Cell Therapy for Parkinson's Disease54%
related📖Endocannabinoid System Dysfunction Hypothesis in Parkinson&#54%
related📖Buntanetap Phase 3 Parkinson's Disease Trial (NCT07284754%
related📖Nigral Microglia in Parkinson's Disease54%
related📖Peroxisome Dysfunction Hypothesis in Parkinson's Diseas54%
related📖Exercise-BDNF Signaling Axis Hypothesis in Parkinson's 54%
related📖International Parkinson's Disease Genetics Consortium54%
related📖Hsp70/Hsp90 Chaperone Pathway in Parkinson's Disease54%
related📖CT1-DAP001 iPS Cell-derived Dopaminergic Progenitors for Par54%
related📖JNK/p38 MAPK Inhibitor Companies for Parkinson's Diseas54%
related📖Taiwanese Biotechnology Companies in Parkinson's Diseas54%
related📖Calcium Channel Dysfunction in Parkinson's Disease54%
related📖NAD+ Precursors (NMN/NR) for Parkinson's Disease54%
related📖Dopamine D3 and D4 Receptor Selective Agonists for Parkinson54%
related📖Wearable Sensors for Parkinson's Disease54%
related📖Sirtuin Signaling in Parkinson's Disease54%
related📖Alpha-Synuclein Propagation in Parkinson's Disease54%
related📖Osteopathic Manipulative Medicine for Parkinson's Disea54%
related📖Axonal Transport Dysfunction Validation in Parkinson's 54%
related📖Gut-Immune-Brain Axis Hypothesis in Parkinson's Disease54%
related📖Mesenchymal Stem Cell Therapy for Parkinson's Disease54%
related📖Astrocyte-Targeted Parkinson's Disease Therapy Companie54%
related📖Korean Biotechnology Companies in Parkinson's Disease54%
related📖Alpha-Synuclein Antisense Therapy for Parkinson's Disea54%
related📖AMPK Signaling in Parkinson's Disease54%
related📖Mesolimbic Dopamine Pathway Neurons in Parkinson's Dise54%
related📖Non-Dopaminergic Neurotransmitter Degeneration as Upstream D54%
related📖TB006 Phase 2a Parkinson's Disease Trial (NCT06773962)54%
related📖LRRK2 Kinase Inhibition in Parkinson's Disease - Therap54%
related📖Pedunculopontine Nucleus Cholinergic Neurons in Parkinson&#x54%
related📖Gut-First vs Brain-First Parkinson's Disease Trajectori54%
related📖ATP13A2 (PARK9) Pathway in Parkinson's Disease54%
related📖Nigrostriatal Dopamine Terminals in Parkinson's Disease54%
related📖alpha-synuclein54%
related📖Alpha-Synuclein Propagation Pathway in Parkinson's Dise54%
related📖Parkinson's Disease54%
related📖GBA Gene Mutations and Parkinson's Disease Risk54%
related📖Neuroinflammation in Parkinson's Disease Dementia and D54%
related📖PINK1 Activators for Parkinson's Disease54%
related📖Natural Killer Cells in Parkinson's Disease54%
related📖Exosome Therapy for Parkinson's Disease54%
related📖Purinergic Receptor Targeted Trials in Parkinson's Dise54%
related📖Mitochondrial Dynamics Dysfunction Hypothesis in Parkinson&#54%
related📖Mindfulness Meditation for Parkinson's Disease54%
related📖Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%
related📖Ferroptosis Hypothesis in Parkinson's Disease54%
related📖Bemdaneprocel for Parkinson's Disease54%
related📖SIRT1 Activators for Parkinson's Disease54%
related📖Silymarin for Neuroprotection and Symptom Management in Park54%
related📖P2X7 Receptor Antagonists for Parkinson's Disease54%
related📖VPS35/Retromer Stabilizers for Parkinson's Disease54%
related📖Prodromal Parkinson's Disease Biomarker Development — E54%
related📖Zonisamide for Parkinson's Disease Motor Complications54%
related📖Lichen-derived Neuroprotective Compounds for Parkinson'54%
related📖NLRP3 Inflammasome Hypothesis in Parkinson's Disease54%
related📖Circadian Rhythm Dysfunction in Parkinson's Disease54%
related📖Laterodorsal Tegmental Nucleus Cholinergic Neurons in Parkin54%
related📖LRRK2 Pathway in Parkinson's Disease54%
related📖Alpha-Synuclein Propagation in Prodromal Parkinson's Di54%
related📖Dopaminergic Neuron Vulnerability in Parkinson's Diseas54%
related📖GGC/Glutathione Antioxidant Enrichment for Parkinson's 54%
related📖Pain and Autonomic Symptoms in Parkinson's Disease and 54%
related📖GPR65 (TDAG8) Modulator Therapy for Parkinson's Disease54%
related📖Physical Exercise Therapy for Parkinson's Disease54%
related📖MPTP Mouse Model of Parkinson's Disease54%
related📖TGF-β Signaling in Parkinson's Disease54%
related📖Theta Deep Brain Stimulation for Cognitive Enhancement in Pa54%
related📖Edmond J Safra Accelerating Clinical Trials in Parkinson54%
related📖Kenai RNDP-001 Dopaminergic Progenitor Cell Therapy for Park54%
related📖cGAS-STING Inhibitors for Parkinson's Disease54%
related📖Tryptophan-Kynurenine Neurotoxicity Hypothesis in Parkinson&54%
related📖Neuroinflammation in Parkinson's Disease54%
related📖Glymphatic-Circadian Axis Dysfunction Hypothesis in Parkinso54%
related📖Mitochondria-Lysosome Contact Site Dysfunction in Parkinson&54%
related📖Phosphodiesterase Inhibitors for Parkinson's Disease54%
related📖Parkinson's Disease Digital Therapeutics Companies54%
related📖DANU Sports System for Gait/Balance Assessment in Parkinson&54%
related📖Astrocytes in Parkinson's Disease Neurodegeneration54%
related📖SAA and Imaging for Prodromal Parkinson's Disease Trial54%
related📖5-Hydroxymethylcytosine (5-hmC) as a Biomarker for Parkinson54%
related📖Gap Junction Dysfunction Hypothesis in Parkinson's Dise54%
related📖Nilotinib for Parkinson's Disease54%
related📖Selegiline - MAO-B Inhibitor for Parkinson's Disease54%
related📖Wnt Signaling in Parkinson's Disease54%
related📖Alpha-Synuclein Prion-Like Spreading Mechanisms in Parkinson54%
related📖Notch and Gamma-Secretase Modulators for Parkinson's Di54%
related📖Probiotic Treatment for Depression in Parkinson's Disea54%
related📖Astrocyte-Targeted Parkinson's Disease Therapies54%
related📖Purinergic Signaling in Parkinson's Disease54%
related📖Optogenetics Therapy for Parkinson's Disease54%
related📖Clostridium Butyricum for Motor and Non-motor Symptoms in Pa54%
related📖Astrocyte-Neuron Metabolic Coupling Hypothesis in Parkinson&54%
related📖MPTP Parkinson's Disease Model54%
related📖mitochondria54%
related📖PINK1/Parkin Pathway in Parkinson's Disease54%
related📖Accelerating Medicines Partnership for Parkinson's Dise54%
related📖Enteric Neurons in Parkinson's Disease54%
related📖Focused Ultrasound for Parkinson's Disease54%
related📖Shared Proteinostasis Failure in Alzheimer's and Parkin54%
related📖Social Behaviors and Quality of Life in Parkinson's Dis54%
related📖Neurovascular Unit Dysfunction in Parkinson's Disease54%
related📖Microglia in Parkinson's Disease Substantia Nigra54%
related📖AAN 2026 — Parkinson's Disease54%
related📖GSK3 Signaling in Parkinson's Disease54%
related📖Regulated Necrosis Validation Study in Parkinson's Dise54%
related📖Entorhinal Cortex in Parkinson's Disease54%
related📖Ubiquitin-Proteasome System Dysfunction in Parkinson's 54%
related📖Dementia with Lewy Bodies vs Parkinson's Disease Compar54%
related📖Extracellular Vesicles in Parkinson's Disease54%
related📖Epigenetic Therapies for Parkinson's Disease54%
related📖Axonal Transport Dysfunction Hypothesis in Parkinson's 54%
related📖SNCA→Alpha-synuclein→Parkinson's Disease Causal Chain54%
related📖Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%
related📖MDS 2026 — Motor Complications in Parkinson's Disease54%
related📖Endocannabinoid System Dysfunction Validation in Parkinson&#54%
related📖events54%
related📖ATP13A9 and Parkinson's Disease54%
related📖Neurovascular Unit Dysfunction Hypothesis in Parkinson'54%
related📖Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%
related📖AMP-PD: Accelerating Medicines Partnership: Parkinson's54%
related📖Tuberoinfundibular Dopamine Neurons in Parkinson's Dise54%
related📖Investment Landscape: Parkinson's Disease54%
related📖Epigenetic Dysregulation Validation in Parkinson's Dise54%
related📖Hippo Signaling Pathway in Parkinson's Disease54%
related📖Parkinson's Disease Subtypes54%
related📖Protein Kinase C (PKC) Signaling in Parkinson's Disease54%
related📖Dopaminergic VTA Neurons in Parkinson's Disease54%
related📖Gut Microbiome-Derived Lipids and Alpha-Synuclein Aggregatio54%
related📖Ferroptosis Validation in Parkinson's Disease54%
related📖EMST with SpiroGym App for Parkinson's Disease (NCT069454%
related📖GBA Glucocerebrosidase Pathway in Parkinson's Disease54%
related📖Mitochondria-Lysosome Contact Site (MLCS) Dysfunction Hypoth54%
related📖Whole-Body Photobiomodulation for Motor and Cognitive Change54%
related📖Parkinson's Disease Mechanisms54%
related📖D2 Striatal Medium Spiny Neurons in Parkinson's Disease54%
related📖Synaptic Dysfunction in Parkinson's Disease54%
related📖Tocotrienols in Parkinson's Disease Trial (NCT04491383)54%
related📖Gut-Immune-Brain Axis Clinical Trial for Parkinson's Di54%
related📖MLCS Quantification Methods in Parkinson's Disease Rese54%
related📖Partnered Dance Aerobic Exercise for Parkinson's Diseas54%
related📖Alpha-Synuclein Propagation Models in Parkinson's Disea54%
related📖VEGF Angiogenesis Therapy for Parkinson's Disease54%
related📖ATP13A2 Lysosomal Dysfunction Parkinson's Disease Causa54%
related📖Exergaming With Physical Objects for Upper Limb Rehabilitati54%
related📖treatments54%
related📖Metal Ion Homeostasis in Parkinson's Disease54%
related📖Selective Vulnerability of Substantia Nigra Dopaminergic Neu54%
related📖Parkin Protein54%
related📖CRISPRi Epigenetic Silencing of SNCA for Parkinson's Di54%
related📖Ferroptosis Therapy for Parkinson's Disease54%
related📖LRRK2 Kinase Activation and Endolysosomal Dysfunction in Par54%
related📖Parkinson's Disease NRF2-Keap1 Pathway Therapy Companie54%
related📖Local Field Potentials of Subthalamic Nucleus in Parkinson&#54%
related📖Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related📖Mitochondria-Lysosome Contact Site Dysfunction in Parkinson&54%
related📖Autophagy-Lysosomal Pathway in Parkinson's Disease54%
related📖Sigma-1 Receptor (SIGMAR1) Signaling in Parkinson's Dis54%
related📖VPS35 Pathway in Parkinson's Disease54%
related📖MDS 2026 — Emerging Therapeutics in Parkinson's Disease54%
related📖Senolytic Therapies for Parkinson's Disease54%
related📖Insulin Signaling in Parkinson's Disease54%
related📖Tissue Engineered Nigrostriatal Pathway for Parkinson's54%
related📖Ultrasonographic Respiratory Muscle Assessment in Parkinson&54%
related📖CVN424 Phase 3 ARISE Trial for Parkinson's Disease54%
related📖HRG2010 for Parkinson's Disease With Motor Fluctuations54%
related📖VA Parkinson's Disease Research Program54%
related📖Psilocybin Therapy for Depression in Parkinson's Diseas54%
related📖Astrocytes in Parkinson's Disease Neurodegeneration54%
related📖cGAS-STING Signaling in Parkinson's Disease54%
related📖Parkin Activators for Parkinson's Disease54%
related📖TREM2 in Parkinson's Disease — Cross-Disease Therapeuti54%
related📖mTOR Signaling in Parkinson's Disease54%
related📖Nucleus Accumbens in Parkinson's Disease54%
related📖Non-Dopaminergic Neurotransmitter System Degeneration Hypoth54%
related📖Photoreceptor Cells in Parkinson's Disease54%
related📖Synaptic Vesicle Trafficking in Parkinson's Disease54%
related📖Circadian Dysregulation in Parkinson's Disease54%
related📖AADC Gene Therapy for Parkinson's Disease54%
related📖Sigma-1 Receptor Agonist Therapy for Parkinson's Diseas54%
related📖SER-252 (PEOZ-Apomorphine) for Parkinson's Disease - NC54%
related📖Epigenetic Regulation Dysfunction in Alzheimer's and Pa54%
related📖Amino Acid Supplement in Parkinson's Disease (NCT06954654%
related📖TREM2 Agonist Therapy for Parkinson's Disease — Experim54%
related📖GCase and Lysosomal Function in Parkinson's Disease54%
related📖Astrocyte Dysfunction in Parkinson's Disease54%
related📖Tai Chi for Parkinson's Disease54%
related📖Epigenetics in Parkinson's Disease54%
related📖VPS35/Retromer Stabilizers for Parkinson's Disease54%
related📖Digital Therapeutic Platform for Swallowing and Drooling Pro54%
related📖VTA Dopamine Neurons in Parkinson's Disease54%
related📖Environmental Toxins and Parkinson's Disease Risk54%
related📖GT-02287 for Parkinson's Disease54%
related📖TFEB Activators for Parkinson's Disease54%
related📖IRL757 for Parkinson's Disease Apathy54%
related📖NURR1 Agonist Therapy for Parkinson's Disease54%
related📖European Academic Spin-out Companies in Parkinson's Dis54%
related📖Parkinson's Disease Synaptic Repair and Preservation Co54%
related📖Lipid Droplet-Lysosome Axis Dysfunction Hypothesis in Parkin54%
related📖PARK2/Parkin Ubiquitin Ligase Pathway in Parkinson's Di54%
related📖ER-Golgi Secretory Pathway Dysfunction Hypothesis in Parkins54%
related📖JAK Inhibitors in Parkinson's Disease54%
related📖Sigma-1 Receptor Agonists for Parkinson's Disease54%
related📖NIH Parkinson's Disease Repurposing Program54%
related📖Synaptic Vesicle Trafficking Dysfunction Hypothesis in Parki54%
related📖Lateral Habenula in Parkinson's Disease54%
related📖ATP13A2 (PARK9) Targeting for Parkinson's Disease54%
related📖LRRK2-GBA Combination Therapy for Parkinson's Disease54%
related📖Vulnerable Neurons in Parkinson's Disease54%
related📖Cionic Neural Sleeve for Parkinson's Disease (NCT07284854%
related📖Post-Acute Viral Reservoir Hypothesis in Parkinson's Di54%
related📖Ventral Tegmental Area Dopamine Neurons in Parkinson's 54%
related📖Dopamine Transporter Modulators for Parkinson's Disease54%
related📖Exercise-BDNF-Mitochondrial Resilience Hypothesis in Parkins54%
related📖Extracellular Vesicle-Mediated Synuclein Propagation Hypothe54%
related📖Cepharanthine (千金藤素) - Investigational Therapy for Parkinson54%
related📖USP30 Inhibitors for Parkinson's Disease54%
related📖Glymphatic System Clearance Dysfunction in Parkinson's 54%
related📖mRNA Therapy for Parkinson's Disease54%
related📖Alpha-Synuclein Aggregation Pathway in Parkinson's Dise54%
related📖MSA Glial Pathology — Detailed Comparison with Parkinson54%
related📖Subthalamic Nucleus in Parkinson's Disease54%
related📖Symptomatic Treatments for Parkinson's Disease54%
related📖FGF13-MTCH2 Neuroprotection in Parkinson's Disease54%
related📖Coenzyme Q10 (CoQ10) for Parkinson's Disease54%
related📖Vagal Nerve Stimulation for Parkinson's Disease (NCT07254%
related📖Physical Therapy for Parkinson's Disease54%
related📖GBA Pathway in Parkinson's Disease54%
related📖RMF Therapy for Parkinson's Disease54%
related📖LRRK2 Inhibitors for Parkinson's Disease54%
related📖Prodromal Parkinson's Disease54%
related📖LRRK2 Pathway in Parkinson's Disease54%
related📖Nrf2 Signaling in Parkinson's Disease54%
related📖Lipid Raft Modulation for Parkinson's Disease (MLSM Hyp54%
related📖Sigma-2 Receptor Modulation for Parkinson's Disease54%
related📖Neurodegeneration54%
related📖Brain-Computer Interface for Parkinson's Disease54%
related📖Neural Oscillation Dysfunction Validation in Parkinson'54%
related📖Calcium Signaling Dysregulation in Parkinson's Disease54%
related📖FMT for Parkinson's Disease54%
related📖Sirtuin Modulator Companies for Parkinson's Disease54%
related📖iPSC Cell Therapy for Parkinson's Disease54%
related📖Dorsal Motor Nucleus of the Vagus in Parkinson's Diseas54%
related📖Melanocytes in Parkinson's Disease54%
related📖GPR37 Modulator Therapy for Parkinson's Disease54%
related📖Parkin54%
related📖GBA Glucocerebrosidase Endolysosomal Pathway in Parkinson&#x54%
related📖NLRP3 Inflammasome Modulation for Parkinson's Disease54%
related📖Dopaminergic Neurons54%
related📖Notch Signaling in Parkinson's Disease54%
related📖ATP13A2/PARK9 Lysosomal Function Therapies for Parkinson54%
related📖Ethnicity-Specific Genetic Architecture Hypothesis in Parkin54%
related📖Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%
related📖Vutiglabridin for Parkinson's Disease54%
related📖Wnt-Beta-Catenin Signaling Dysfunction Hypothesis in Parkins54%
related📖Nigral Glia in Parkinson's Disease54%
related📖Parkinson's Disease Treatment Options54%
related📖Interpeduncular Nucleus Cholinergic Neurons in Parkinson54%
related📖CUE1 Non-Invasive Vibrotactile Device for Parkinson's D54%
related📖Parkinson's Disease Investment Landscape54%
related📖Acupuncture Therapy for Parkinson's Disease54%
related📖Photobiomodulation Therapy for Parkinson's Disease54%
related📖Physical Activity Effects on Mitochondrial Function in Parki54%
related📖NUS1 CoQ10 Pathway Modulation for Parkinson's Disease54%
related📖Parkinson's Disease Metabolism54%
related📖Retromer-Endosomal Sorting Dysfunction Hypothesis in Parkins54%
related📖Olfactory Bulb Neurons in Parkinson's Disease54%
related📖Occupational Therapy for Parkinson's Disease54%
related📖Synaptic Plasticity Therapeutics for Parkinson's Diseas54%
related📖H₂S-Releasing Compounds Therapy for Parkinson's Disease54%
related📖Dopamine54%
related📖Efficacy of Acupuncture for Treatment of Parkinson's Di54%
related📖G-Protein Coupled Receptor Signaling in Parkinson's Dis54%
related📖GBA and Lysosomal Function in Parkinson's Disease54%
related📖FGF Signaling in Parkinson's Disease54%
related📖LRRK2 Signaling Pathway in Parkinson's Disease54%
related📖AI-Powered Movement Analysis for Parkinson's Disease54%
related📖Protein Phase Separation in Parkinson's Disease54%
related📖MLCS Quantification in Parkinson's Disease54%
related📖Ubiquitin-Proteasome System Therapeutic Companies for Parkin54%
related📖Parkinson's Disease Treatment54%
related📖Pain in Parkinson's Disease: Exploration of the Seroton54%
related📖ASO Therapy for Parkinson's Disease54%
related📖GDNF Therapy for Parkinson's Disease54%
related📖Parkinson's Disease Treatment Overview54%
related📖PI3K/Akt Signaling in Parkinson's Disease54%
related📖Ferroptosis in Parkinson's Disease54%
related📖Microbiome-Gut-Brain Axis in Parkinson's Disease54%
related📖Apoptosis Pathways in Parkinson's Disease54%
related📖Stress Granule Dysfunction Validation in Parkinson's Di54%
related📖Cognitive Rehabilitation for Parkinson's Disease54%
related📖Prasinezumab Phase 3 Parkinson's Disease Trial (NCT071754%
related📖Parkinson's Disease DNA Damage Repair Therapeutic Compa54%
related📖CSF1R Inhibitors for Parkinson's Disease54%
related📖Paolo Barone — Parkinson's Disease and Movement Disorde54%
related📖Neurotensin Receptor Modulators for Parkinson's Disease54%
related📖DNA Damage Repair Deficiency Hypothesis in Parkinson's 54%
related📖TMEM175 Lysosomal Overflow Valve in Parkinson's Disease54%
related📖mechanisms54%
related📖Neurovascular Unit Function Assessment in Parkinson's D54%
related📖NCT05881460: Vibrotactile Coordinated Reset for Parkinson&#x54%
related📖Tributyrin for Parkinson's Disease54%
related📖Epigenetic Dysregulation Hypothesis in Parkinson's Dise54%
related📖Vagus Nerve Stimulation for Parkinson's Disease54%
related📖Pallido-thalamocortical Motor Pathway in Parkinson's Di54%
related📖GLP-1 Receptor Agonists for Parkinson's Disease54%
related📖Non-Motor Symptom Progression in Parkinson's Disease — 54%
related📖Mediterranean Diet in Parkinson's Disease (NCT07187739)54%
related📖cGAS-STING Pathway Validation Study in Parkinson's Dise54%
related📖Mitochondria54%
related📖Antiviral Therapy Trial for Parkinson's Disease54%
related📖Enteric Glial Cells in Parkinson's Disease54%
related📖Adaptive Deep Brain Stimulation to Offset STN Dysregulation 54%
related📖PSAP-GPR37-IL-6 Axis in Parkinson's Disease54%
related📖Striatal Cholinergic Interneurons in Parkinson's Diseas54%
related📖Exenatide for Parkinson's Disease54%
related📖NCT06530290: Mirtazapine for Anxiety in Parkinson's Dis54%
related📖Dopamine Transporters in Parkinson's Disease54%
related📖Parkinson's Disease EGFR Signaling Therapy Companies54%
related📖hypotheses54%
related📖PGC-1α and Mitochondrial Biogenesis Therapies for Parkinson&54%
related📖Neuro-immune Interactome in Parkinson's Disease (NCT07054%
related📖Vesicular Monoamine Transporter 2 (VMAT2) Pathway in Parkins54%
related📖Combination Therapy Sequencing in Parkinson's Disease54%
related📖Alpha-Synuclein Seed Kinetic Staging in Parkinson's Dis54%
related📖Digital Therapeutics for Parkinson's Disease54%
related📖Blood Flow Restriction for Optimizing Balance in Parkinson&#54%
related📖Spinal Cord Stimulation (SCS) for Parkinson's Disease54%
related📖Neuroinflammation in Parkinson's Disease54%
related📖SGLT2 Inhibitors for Parkinson's Disease54%
related📖neuroimaging54%
related📖Vagal Nucleus Neurons in Parkinson's Disease54%
related📖Polygenic Risk Score Integration Panel for Alzheimer's 54%
related📖Icaritin GPER Mitophagy for Parkinson's Disease54%
related📖Raphe Nucleus Serotonergic Neurons in Parkinson's Disea54%
related📖CAR-T Cell Therapy for Parkinson's Disease54%
related📖Dopamine Transporter (DAT) Dysfunction Pathway in Parkinson&54%
related📖GBA Therapy in Parkinson's Disease54%
related📖EC5026 (STEP Study) - Parkinson's Disease Clinical Tria54%
related📖Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%
related📖ACI-35 Alpha-Synuclein Vaccine for Parkinson's Disease54%
related📖Parkinson's Disease Dementia (PDD)54%
mentions📖Mitochondria-Lysosome Contact Site Dysfunction in Parkinson&50%
mentions📖Ceruloplasmin (CP)50%
mentions📖Mitochondria-Lysosome Contact Sites (MLCS) in Neurodegenerat50%
mentions📖Pedunculopontine Nucleus Cholinergic Neurons in Lewy Body Di50%
mentions📖Mitochondrial Dynamics50%
mentions📖connexin-pannexin-hemichannel-modulation50%
mentions📖Cerebellar Purkinje Cells50%
mentions📖Cerebrovascular Disease in Neurodegeneration50%
mentions📖IVNS1ABP Mutation: Progeria-Like Disease with Neurological D50%
mentions📖Mitochondria-Lysosome Contact Site (MLCS) Dysfunction Hypoth50%
mentions📖Mitochondria-Lysosome Contact Sites Dysfunction in Parkinson50%
mentions📖FOXO Signaling Pathway in Neurodegeneration50%
mentions📖Parkinson Basal Ganglia Circuit50%
mentions📖Connexin and Pannexin Hemichannel Signaling in Neurodegenera50%
mentions📖Cerebellar Granule Cells in Neurodegenerative Disease50%
mentions📖Parkin (PARK2)50%
mentions📖Mitochondria-Lysosome Contact Site Dysfunction in Parkinson&50%
mentions📖cross-disease50%
mentions📖Mitochondria-Lysosome Contact Sites in Parkinson's Dise50%
mentions📖Spinal Cord Interneurons in Motor Neuron Disease50%
mentions📖TFAM Gene50%
mentions📖MCU Gene50%
mentions📖Connexin 43 (Cx43) Gap Junction Modulation Therapy50%
mentions📖PARKIN Gene50%
mentions📖Pedunculopontine Nucleus Neurons in Lewy Body Disease50%
mentions📖Brainstem50%
mentions📖Cerebellar Neurons in Creutzfeldt-Jakob Disease50%
mentions📖Mitochondria in Neurodegeneration50%
mentions📖Section 193 Advanced Integrated Cell Stress Response Therapy44%
mentions📖Pial Cells44%
mentions📖Enteric Glial Cells in Parkinson Disease44%
mentions📖Enteric Glial Cells44%
mentions📖Enteric Glial Cells44%
mentions📖P300 Brain-Computer Interface44%
mentions📖Enteric Glial Cells44%
mentions📖Enteric Glial Cells in Neurodegeneration44%
mentions📖Transcription Regulation Pathway44%
mentions📖Enteric Glial Cells in Parkinson's Disease44%
mentions📖SLC6A1 Connect44%
mentions📖Mitochondrial Dysfunction in Dopaminergic Neurons44%
mentions📖Lysosomal Storage Disorders44%
mentions📖astrocyte-modulation-therapy44%
mentions📖Proteins44%
mentions📖Caudate Nucleus Projection Neurons44%
mentions📖Astrocytes44%
mentions📖Radial Glia44%
mentions📖Parkinson's Disease40%
mentions📖Parkinson Disease40%

💬 Discussion

SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub